Pharmaceutical Technology

JULY 18, 2022

GlaxoSmithKline (GSK) has signed an agreement with the Government of Canada for pandemic and seasonal influenza vaccines to aid in protecting adults and children in the country. The company intends to supply both vaccines from its 230,000ft² Sainte-Foy facility in Quebec. .

Vaccines 64

Vaccines Immunization 64

European Pharmaceutical Review

DECEMBER 12, 2023

He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. We specialise in the development of new cutting-edge immunotherapies , based on the use of therapeutic antibodies capable of activating the immune system to fight cancer.

Immunization 107

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 107

The People's Pharmacy

JUNE 1, 2023

According to the CDC: “Human metapneumovirus (HMPV) can cause upper and lower respiratory disease in people of all ages, especially among young children, older adults, and people with weakened immune systems. Discovered in 2001, HMPV is in the Pneumoviridae family along with respiratory syncytial virus (RSV).”

Vaccines 71

Vaccines Immunization FDA 71

pharmaphorum

DECEMBER 10, 2020

He was responsible for the national immunisation programme and led the introduction of many new vaccines. He previously chaired the WHO’s Strategic Advisory Group of Experts on Immunization, the WHO committee that sets global immunisation policy. He was made a Companion of the Order of the Bath in 2001.

Communication 52

Communication Immunization Vaccines 52

PharmaShots

FEBRUARY 21, 2023

Nordic is advancing the development of CD37-targeted therapies for hematological cancers and immune diseases. Under its cancer therapy products, the company develops low molecular drugs, antibody drugs, cancer peptide vaccines, and diagnostic medicines.

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56

pharmaphorum

MARCH 9, 2021

SARS-CoV-2 is likely to stay endemic in the human population for the foreseeable future, ExeVir noted, with variants capable of evading immunity the most likely cause of the disease in the future as global vaccination programmes begin to take effect. ExeVir is not the first company to spin out of VIB to focus on camelid antibodies.

Immunization 98

Immunization Vaccines FDA 98

The Checkup by Singlecare

MARCH 28, 2024

Without cell walls, bacteria can’t survive and are more easily cleared by your immune system. In a 2001 study that compared azithromycin to amoxicillin for the treatment of chlamydia in pregnancy, cure rates of both drugs were high. Many STDs can be cured with the proper treatment.

Dosage 97

Dosage FDA Labelling Communication 97